Bunsua, Merly L.
HRN: 29-05-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/19/2026
06/26/2026
IV
600mg
Q8H
INFECTED BREAST MASS
Checking Initial Appropriateness
06/19/2026
MUPIROCIN 2%, 15G (TUBE)
06/19/2026
06/26/2026
IV
2%
BID
Infected Breast Mass
Checking Initial Appropriateness
06/19/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/19/2026
06/25/2026
IV
500mg
Q8
Infected Breast Mass, Left
Checking Initial Appropriateness